(Photo provided) Coplin Health Systems is offering a second mobile health unit. PARKERSBURG — Coplin Health Systems has added a second mobile health unit in an effort to reach more individuals and ...

Thermo Fisher (NYSE:TMO) is nearing a takeover of Clario in an all-cash deal that could value the clinical trial data management firm at around $10B, the Financial Times reported, citing people ...

These cells are simultaneously under the direct influence of the gut microbiota, 1 leading some to refer to the network by the longer name “microbiota-gut-brain axis.” As these immune, endocrine, and ...

Osteoarthritis (OA) is the most common chronic joint disease worldwide. Increasing studies have confirmed that obesity, metabolic status and gut microbiota imbalance can promote the occurrence of OA ...

Clinical software developer PhaseV is teaming up with another global CRO, unveiling a plan to infuse its trial design platform into Bioforum’s services. PhaseV’s Trial Optimizer uses machine learning ...

Emerging insights into the gut-lung axis continue to open new possibilities for managing chronic respiratory diseases, from cystic fibrosis (CF) in the youngest patients to chronic obstructive ...

CEO Ramy Farid highlighted "very solid progress in the first half of 2025" with total revenue of $54.8 million in the second quarter, a 16% increase year-over-year. Software revenue reached $40.5 ...

Thousands of organizations could be vulnerable to attack after researchers discovered four critical vulnerabilities in the products of Axis Communications, a leading manufacturer of CCTV cameras and ...

McGill University researchers have developed and are licensing a digital tool to help safely reduce patients' use of medications that may be unnecessary or even harmful to them. "Sometimes we blame ...